Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma.

Kern DH, Shoemaker RH, Hildebrand-Zanki SU, Driscoll JS.

Cancer Res. 1988 Sep 15;48(18):5178-82.

2.
3.

Clinical application of the thymidine incorporation assay.

Kern DH, Sondak VK, Morgan CR, Hildebrand-Zanki SU.

Ann Clin Lab Sci. 1987 Nov-Dec;17(6):383-8.

PMID:
3688821
4.
5.

Growth inhibitory effect of sodium azide in chemosensitivity assays.

Sondak VK, Hildebrand-Zanki SU, Butler A, Kern DH.

Int J Cell Cloning. 1987 May;5(3):191-201.

PMID:
2439615
6.

A rapid bioassay to determine stabilities of anticancer agents under conditions of the clonogenic assay.

Hildebrand-Zanki SU, Kern DH.

In Vitro Cell Dev Biol. 1986 May;22(5):247-52.

PMID:
3710996
7.

Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors.

Kern DH, Drogemuller CR, Kennedy MC, Hildebrand-Zanki SU, Tanigawa N, Sondak VK.

Cancer Res. 1985 Nov;45(11 Pt 1):5436-41.

8.

Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay.

Sondak VK, Bertelsen CA, Tanigawa N, Hildebrand-Zanki SU, Morton DL, Korn EL, Kern DH.

Cancer Res. 1984 Apr;44(4):1725-8.

Supplemental Content

Loading ...
Support Center